Cited 0 times in Scipus Cited Count

PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin

DC Field Value Language
dc.contributor.authorBae, WJ-
dc.contributor.authorAhn, JM-
dc.contributor.authorByeon, HE-
dc.contributor.authorKim, S-
dc.contributor.authorLee, D-
dc.date.accessioned2022-01-14T05:16:57Z-
dc.date.available2022-01-14T05:16:57Z-
dc.date.issued2019-
dc.identifier.issn0392-9078-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/19979-
dc.description.abstractBACKGROUND: Protein tyrosine phosphatase receptor delta (PTPRD) is frequently inactivated in various types of cancers. Here, we explored the underlying mechanism of PTPRD-loss-induced cancer metastasis and investigated an efficient treatment option for PTPRD-inactivated gastric cancers (GCs).
METHODS: PTPRD expression was evaluated by immunohistochemistry. Microarray analysis was used to identify differentially expressed genes in PTPRD-inactivated cancer cells. Quantitative reverse transcription (qRT-PCR), western blotting, and/or enzyme-linked immunosorbent assays were used to investigate the PTPRD-CXCL8 axis and the expression of other related genes. An in vitro tube formation assay was performed using HUVECs. The efficacy of metformin was assessed by MTS assay.
RESULTS: PTPRD was frequently downregulated in GCs and the loss of PTPRD expression was associated with advanced stage, worse overall survival, and a higher risk of distant metastasis. Microarray analysis revealed a significant increase in CXCL8 expression upon loss of PTPRD. This was validated in various GC cell lines using transient and stable PTPRD knockdown. PTPRD-loss-induced angiogenesis was mediated by CXCL8, and the increase in CXCL8 expression was mediated by both ERK and STAT3 signaling. Thus, specific inhibitors targeting ERK or STAT3 abrogated the corresponding signaling nodes and inhibited PTPRD-loss-induced angiogenesis. Additionally, metformin was found to efficiently inhibit PTPRD-loss-induced angiogenesis, decrease cell viability in PTPRD-inactivated cancers, and reverse the decrease in PTPRD expression.
CONCLUSIONS: Thus, the PTPRD-CXCL8 axis may serve as a potential therapeutic target, particularly for the suppression of metastasis in PTPRD-inactivated GCs. Hence, we propose that the therapeutic efficacy of metformin in PTPRD-inactivated cancers should be further investigated.
-
dc.subject.MESHCell Line, Tumor-
dc.subject.MESHDown-Regulation-
dc.subject.MESHGene Silencing-
dc.subject.MESHHumans-
dc.subject.MESHHypoglycemic Agents-
dc.subject.MESHInterleukin-8-
dc.subject.MESHMetformin-
dc.subject.MESHNeoplasm Metastasis-
dc.subject.MESHNeovascularization, Pathologic-
dc.subject.MESHReceptor-Like Protein Tyrosine Phosphatases, Class 2-
dc.subject.MESHSignal Transduction-
dc.subject.MESHStomach Neoplasms-
dc.subject.MESHTransfection-
dc.titlePTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin-
dc.typeArticle-
dc.identifier.pmid31805999-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896474/-
dc.subject.keywordAngiogenesis-
dc.subject.keywordCXCL8-
dc.subject.keywordGastric cancer-
dc.subject.keywordMetastasis-
dc.subject.keywordPTPRD-
dc.contributor.affiliatedAuthorByeon, HE-
dc.contributor.affiliatedAuthorLee, D-
dc.type.localJournal Papers-
dc.identifier.doi10.1186/s13046-019-1469-4-
dc.citation.titleJournal of experimental & clinical cancer research : CR-
dc.citation.volume38-
dc.citation.number1-
dc.citation.date2019-
dc.citation.startPage484-
dc.citation.endPage484-
dc.identifier.bibliographicCitationJournal of experimental & clinical cancer research : CR, 38(1). : 484-484, 2019-
dc.identifier.eissn1756-9966-
dc.relation.journalidJ003929078-
Appears in Collections:
Journal Papers > Research Organization > Institute for Medical Sciences
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Files in This Item:
31805999.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse